Cutaneous Manifestations in Adults With Gender Dysphoria Undergoing Hormonal Treatment at the Hospital De San José, Bogotá Colombia

    October 2023 in “ Journal of the Endocrine Society ”
    Henry Tovar Cortes
    Image of study
    TLDR Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.
    The study "Cutaneous Manifestations In Adults With Gender Dysphoria Under Treatment Hormonal In External Consultation Of The Hospital De San José , Bogotá Colombia" is a cross-sectional descriptive observational study that analyzed the skin manifestations secondary to hormonal treatment in adults with gender dysphoria. The study included 85 patients, predominantly young transgender men, treated at the San José Hospital of Bogotá between 2015 and 2021. The main skin manifestation was acne (90%), followed by androgenetic alopecia and acanthosis nigricans. Transgender women presented more acne, androgenetic alopecia, seborrheic dermatitis, and melasma. More than half of the patients were seen by both endocrinology and dermatology departments, receiving mainly topical treatment. The study concludes that skin manifestations in patients with gender dysphoria undergoing hormonal therapy are frequent and should be considered in the multidisciplinary approach to these patients, including the involvement of a dermatologist.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 466 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 5 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  64 upvotes 11 months ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community Getting Ed from 1mg of fin not sure what to do

      in Finasteride  190 upvotes 1 month ago
      The user experienced erectile dysfunction from 1mg finasteride and sought advice on whether to continue, reduce dosage, or switch treatments. Suggestions included switching to topical finasteride, adding minoxidil, or trying dutasteride.

    Similar Research

    5 / 1000+ results